Clinical Trials Update:&nbsp;Sept. 17, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
524483
roundup Plus: Sprint to bake in BlackBerry for businesses...Microsoft ships updated Works...FaceTime pulls in $16 million.
532860
WASHINGTON -- The Food and Drug Administration will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
284089
roundup Plus: SAS Institute lures former Red Hat CFO...McAfee CFO joins Cray board...Unisys boosts COO to CEO...Turn your fingerprints into passwords.
535175
BioSante releases more info on the pivotal studies for its lead drug.
537489
Logitech International unveils the world's first computer mouse to use a sensor based on a laser. Also: Nintendo slashes some prices & hellip;. Sales of Boston Scientific's new heart stent dip & hellip;. and more.
315060
roundup Plus: IronPort spam shield gets steelier...Via brings PCI Express to AMD PCs...Rice lab makes nano parts less toxic.
400180
Description: A new study finds that deaths in cancer drug trials have declined ten-fold, thanks to the development of drugs that are better targeted at the tumors themselves.
554707
NEWS: In 2002, weeks before President Bush announced a plan to protect African babies from AIDS, top US health officials were warned that research about the drug, nevirapine, was flawed
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
329386
roundup Plus: Dell updates low-end server line...SAS Institute lures former Red Hat CFO...McAfee CFO joins Cray board.
103036
A trial of a new type of schizophrenia drug shows promise in patients.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
456511
Compiled by PAUL MONTELLA Sept. 19
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.